chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Hypernatraemia, Hypoxia, Influenza virus test negative, Lung infiltration, Mental status changes
Clinical narrative: Patient is a 54 y.o. female patient of MD with history of MRDD, COPD, asthma, urea cycle metabolism disorder, stereotypic movement disorder, Raynaud's disease, organic personality syndrome, and convulsions who presented to Mansfield Hospital from a group home with shortness of breath.   Sepsis  Acute hypoxemic respiratory failure COVID Pneumonia COPD/Asthma The patient presented from a group home with shortness of breath.   COVID positive, Influenza negative.  Blood Cult x2 (10/22)- NGTD CXR (10/22)-showed bibasilar predominant infiltrates Sputum culture, MRSA swab, UA/culture negative ID followed, critical care followed Finished dexamethasone and remdesivir course Continue bronchodilators Weaned off BiPAP, currently on nasal cannula DC telemetry Discontinue COVID isolation on 11/2       Altered Mental Status possible acute metabolic encephalopathy secondary to hypoxia Likely in the setting of respiratory acidosis, elevated CO2 Weaned off BiPAP Initially had been holding clonazepam, seroquel, and risperdal  Slowly start to resume back medications per neurology Wean off Precedex as able continue monitor mental status Neurology followed - recommendations increase Seroquel, continue carbamazepine, topiramate, Keppra   Shock Likely secondary to sedation Has resolved, continue monitor blood pressure closely MRDD Insomnia Home medications include; benztropine, carbamazepine, clonazepam, doxepin, escitalopram, melatonin, Seroquel, risperidone, and topiramate Had been holding clonazepam, Seroquel, and risperdal Started back on Seroquel, risperidone   Bradycardia Likely due to Precedex, will continue to monitor Avoid AV nodal blockers Improved   Mild hypernatremia with sodium 147 likely due to inadequate fluid intake Acute kidney injury with creatinine 1.1 on 11/1 Half-normal saline at rate 70 mill per hour started on 11/1 Sodium improving today 147 and kidney function back to normal 0.08
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Positive airway pressure therapy, Renal impairment, Respiratory acidosis, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Patient is a 54 y.o. female patient of MD with history of MRDD, COPD, asthma, urea cycle metabolism disorder, stereotypic movement disorder, Raynaud's disease, organic personality syndrome, and convulsions who presented to Mansfield Hospital from a group home with shortness of breath.   Sepsis  Acute hypoxemic respiratory failure COVID Pneumonia COPD/Asthma The patient presented from a group home with shortness of breath.   COVID positive, Influenza negative.  Blood Cult x2 (10/22)- NGTD CXR (10/22)-showed bibasilar predominant infiltrates Sputum culture, MRSA swab, UA/culture negative ID followed, critical care followed Finished dexamethasone and remdesivir course Continue bronchodilators Weaned off BiPAP, currently on nasal cannula DC telemetry Discontinue COVID isolation on 11/2       Altered Mental Status possible acute metabolic encephalopathy secondary to hypoxia Likely in the setting of respiratory acidosis, elevated CO2 Weaned off BiPAP Initially had been holding clonazepam, seroquel, and risperdal  Slowly start to resume back medications per neurology Wean off Precedex as able continue monitor mental status Neurology followed - recommendations increase Seroquel, continue carbamazepine, topiramate, Keppra   Shock Likely secondary to sedation Has resolved, continue monitor blood pressure closely MRDD Insomnia Home medications include; benztropine, carbamazepine, clonazepam, doxepin, escitalopram, melatonin, Seroquel, risperidone, and topiramate Had been holding clonazepam, Seroquel, and risperdal Started back on Seroquel, risperidone   Bradycardia Likely due to Precedex, will continue to monitor Avoid AV nodal blockers Improved   Mild hypernatremia with sodium 147 likely due to inadequate fluid intake Acute kidney injury with creatinine 1.1 on 11/1 Half-normal saline at rate 70 mill per hour started on 11/1 Sodium improving today 147 and kidney function back to normal 0.08
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Sputum culture, Staphylococcus test negative, Urine analysis normal
Clinical narrative: Patient is a 54 y.o. female patient of MD with history of MRDD, COPD, asthma, urea cycle metabolism disorder, stereotypic movement disorder, Raynaud's disease, organic personality syndrome, and convulsions who presented to Mansfield Hospital from a group home with shortness of breath.   Sepsis  Acute hypoxemic respiratory failure COVID Pneumonia COPD/Asthma The patient presented from a group home with shortness of breath.   COVID positive, Influenza negative.  Blood Cult x2 (10/22)- NGTD CXR (10/22)-showed bibasilar predominant infiltrates Sputum culture, MRSA swab, UA/culture negative ID followed, critical care followed Finished dexamethasone and remdesivir course Continue bronchodilators Weaned off BiPAP, currently on nasal cannula DC telemetry Discontinue COVID isolation on 11/2       Altered Mental Status possible acute metabolic encephalopathy secondary to hypoxia Likely in the setting of respiratory acidosis, elevated CO2 Weaned off BiPAP Initially had been holding clonazepam, seroquel, and risperdal  Slowly start to resume back medications per neurology Wean off Precedex as able continue monitor mental status Neurology followed - recommendations increase Seroquel, continue carbamazepine, topiramate, Keppra   Shock Likely secondary to sedation Has resolved, continue monitor blood pressure closely MRDD Insomnia Home medications include; benztropine, carbamazepine, clonazepam, doxepin, escitalopram, melatonin, Seroquel, risperidone, and topiramate Had been holding clonazepam, Seroquel, and risperdal Started back on Seroquel, risperidone   Bradycardia Likely due to Precedex, will continue to monitor Avoid AV nodal blockers Improved   Mild hypernatremia with sodium 147 likely due to inadequate fluid intake Acute kidney injury with creatinine 1.1 on 11/1 Half-normal saline at rate 70 mill per hour started on 11/1 Sodium improving today 147 and kidney function back to normal 0.08
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: VACCINE FROZEN INSTEAD OF REFRIGERATED
Age: 41.0
Sex: F
Vaccine: FLU4
Symptoms: Injected limb mobility decreased, Muscular weakness, Pain
Clinical narrative: 12/27/23 - Named individual contacted Employee Health today stating that her right arm has become weaker since the date of flu vaccine administration and she is unable to lift arm above head without pain; waited until today to see if pain would go away; Occupational Health visit being arranged
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: None stated.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: hospitalized with COVID
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE GIVEN AFTER VIABILITY DATE.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Blood creatinine increased, COVID-19, Chest X-ray abnormal, Chronic fatigue syndrome
Clinical narrative: Patient is a 81 y.o. male patient of CNP with history of COPD, chronic hypoxemic respiratory failure on 4 to 5 L of oxygen at home, atrial fibrillation, congestive heart failure, aortic valve disease s/p TAVR, hypertension, hepatitis B and pulmonary hypertension presented to Hospital with weakness on 10/31/2023.   The following describes as Hospital course by problem:   Covid-19 Virus Infection Date of onset of symptoms: 10/25/2023 Symptoms present on admission: Weakness Date of covid positive test: 10/31/23 Vaccination status: vaccinated Imaging: CXR with chronic interstitial changes Oxygen requirements on admission: 5 Lpm (baseline 5 Lpm) Current oxygen requirements: 5 Lpm Medical therapy: Started on IV remdesivir first dose 11/03 and IV Decadron Consultants following: ID Infectious disease following and completed course of remdesivir while inpatient and treated with steroids.  At baseline respiratory status at time of discharge.   Chronic hypoxemic respiratory failure COPD Severe pulmonary hypertension, Baseline oxygen 4 to 5 Lpm by NC Continue Spiriva, Dulera Albuterol PRN   Generalized weakness: Chronic fatigue syndrome Ambulatory dysfunction Evaluated by therapy Declined home health services   Chronic kidney disease Creatinine baseline ranging around 1.3 Monitor BMP daily And euvolemic continue home med torsemide Cr down to 1.06  Chronic diastolic heart failure:  Remains euvolemic Continue torsemide Continue home medications including metoprolol   Severe pulmonary hypertension: Continue riociguat 3 times daily   HTN: Norvasc, Toprol   Atrial fibrillation S/p Amulet device implantation; scheduled for CTA and possible discontinuation of anticoagulation in future Continue home meds Tikosyn, Toprol and Coumadin Follow-up with INR clinic on Monday     Chronic Anemia Iron deficiency Currently on ferrous sulfate 325 mg p.o. daily   Depression/bipolar Abilify Sertraline   HLD: Atovastatin   GERD: Famotidine
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chronic kidney disease, Gait disturbance, Interstitial lung disease, Malaise, SARS-CoV-2 test positive
Clinical narrative: Patient is a 81 y.o. male patient of CNP with history of COPD, chronic hypoxemic respiratory failure on 4 to 5 L of oxygen at home, atrial fibrillation, congestive heart failure, aortic valve disease s/p TAVR, hypertension, hepatitis B and pulmonary hypertension presented to Hospital with weakness on 10/31/2023.   The following describes as Hospital course by problem:   Covid-19 Virus Infection Date of onset of symptoms: 10/25/2023 Symptoms present on admission: Weakness Date of covid positive test: 10/31/23 Vaccination status: vaccinated Imaging: CXR with chronic interstitial changes Oxygen requirements on admission: 5 Lpm (baseline 5 Lpm) Current oxygen requirements: 5 Lpm Medical therapy: Started on IV remdesivir first dose 11/03 and IV Decadron Consultants following: ID Infectious disease following and completed course of remdesivir while inpatient and treated with steroids.  At baseline respiratory status at time of discharge.   Chronic hypoxemic respiratory failure COPD Severe pulmonary hypertension, Baseline oxygen 4 to 5 Lpm by NC Continue Spiriva, Dulera Albuterol PRN   Generalized weakness: Chronic fatigue syndrome Ambulatory dysfunction Evaluated by therapy Declined home health services   Chronic kidney disease Creatinine baseline ranging around 1.3 Monitor BMP daily And euvolemic continue home med torsemide Cr down to 1.06  Chronic diastolic heart failure:  Remains euvolemic Continue torsemide Continue home medications including metoprolol   Severe pulmonary hypertension: Continue riociguat 3 times daily   HTN: Norvasc, Toprol   Atrial fibrillation S/p Amulet device implantation; scheduled for CTA and possible discontinuation of anticoagulation in future Continue home meds Tikosyn, Toprol and Coumadin Follow-up with INR clinic on Monday     Chronic Anemia Iron deficiency Currently on ferrous sulfate 325 mg p.o. daily   Depression/bipolar Abilify Sertraline   HLD: Atovastatin   GERD: Famotidine
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19
Clinical narrative: hospitalized with covid
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE GIVEN AFTER VIABILITY DATE
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Acute respiratory failure, Alanine aminotransferase increased, Back pain, Blood sodium normal
Clinical narrative: Patient is a 87 y.o. male patient of DO with history of  afib, arthritis, CA, CKD, CAD, GERD, HTN, HLD, MI   presented to Hospital with abdominal pain, back pain.   Acute pancreatitis Noted on CT scan, but with normal lipase No obvious etiology.  Denies alcohol use. Molnupiravir is not noted to cause pancreatitis. Consult GI. Cautiously hydrate this patient who has concurrent COVID-pneumonia. PPI ordered RUQ ultrasound unremarkable 10/30 MRCP showed atrophic changes of the pancreas with areas of fatty infiltration persistent edematous appearance of the caudal aspect of the pancreatic head and process with a small cyst developing pseudocyst in the region.  Recommend short interval MRI pancreas in 1 to 3 months as outpatient.   GI also recommending EUS in 6 to 8 weeks Tolerating regular diet 11/1   Covid-19 Virus Infection with viral pneumonia Acute Hypoxemic Respiratory Failure-improved Date of onset of symptoms: 10/24 Symptoms present on admission: Cough, fever, congestion Date of covid positive test: 1024 Vaccination status: vaccinated Imaging: CXR -Mildly increased perihilar and bibasilar opacities could represent atypical infection and/or edema.  Oxygen requirements on admission: 3L/NC Current oxygen requirements: room air Medical therapy: remdesivir and steroids Anticipated special isolation end date: 11/5 PO Decadron x 6 more days (End date 11/8/23)   Mildly Elevated ALT In the setting of above Monitored LFT's closely in the setting of Remdesevir infusion Improved and almost resolved 156 on admission->52 11/2 Follow with PCP for repeat in 1-2 weeks   Atrial fibrillation Bradycardia Continue home amiodarone and Eliquis Essential HTN Controlled Continue home meds   Hyponatremia - resolved Na+ 137 (11/2)   Constipation - resolved BM documented on 10/31/23
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram abdomen abnormal, Constipation
Clinical narrative: Patient is a 87 y.o. male patient of DO with history of  afib, arthritis, CA, CKD, CAD, GERD, HTN, HLD, MI   presented to Hospital with abdominal pain, back pain.   Acute pancreatitis Noted on CT scan, but with normal lipase No obvious etiology.  Denies alcohol use. Molnupiravir is not noted to cause pancreatitis. Consult GI. Cautiously hydrate this patient who has concurrent COVID-pneumonia. PPI ordered RUQ ultrasound unremarkable 10/30 MRCP showed atrophic changes of the pancreas with areas of fatty infiltration persistent edematous appearance of the caudal aspect of the pancreatic head and process with a small cyst developing pseudocyst in the region.  Recommend short interval MRI pancreas in 1 to 3 months as outpatient.   GI also recommending EUS in 6 to 8 weeks Tolerating regular diet 11/1   Covid-19 Virus Infection with viral pneumonia Acute Hypoxemic Respiratory Failure-improved Date of onset of symptoms: 10/24 Symptoms present on admission: Cough, fever, congestion Date of covid positive test: 1024 Vaccination status: vaccinated Imaging: CXR -Mildly increased perihilar and bibasilar opacities could represent atypical infection and/or edema.  Oxygen requirements on admission: 3L/NC Current oxygen requirements: room air Medical therapy: remdesivir and steroids Anticipated special isolation end date: 11/5 PO Decadron x 6 more days (End date 11/8/23)   Mildly Elevated ALT In the setting of above Monitored LFT's closely in the setting of Remdesevir infusion Improved and almost resolved 156 on admission->52 11/2 Follow with PCP for repeat in 1-2 weeks   Atrial fibrillation Bradycardia Continue home amiodarone and Eliquis Essential HTN Controlled Continue home meds   Hyponatremia - resolved Na+ 137 (11/2)   Constipation - resolved BM documented on 10/31/23
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Hyponatraemia, Lipase normal, Lung opacity, Magnetic resonance cholangiopancreatography
Clinical narrative: Patient is a 87 y.o. male patient of DO with history of  afib, arthritis, CA, CKD, CAD, GERD, HTN, HLD, MI   presented to Hospital with abdominal pain, back pain.   Acute pancreatitis Noted on CT scan, but with normal lipase No obvious etiology.  Denies alcohol use. Molnupiravir is not noted to cause pancreatitis. Consult GI. Cautiously hydrate this patient who has concurrent COVID-pneumonia. PPI ordered RUQ ultrasound unremarkable 10/30 MRCP showed atrophic changes of the pancreas with areas of fatty infiltration persistent edematous appearance of the caudal aspect of the pancreatic head and process with a small cyst developing pseudocyst in the region.  Recommend short interval MRI pancreas in 1 to 3 months as outpatient.   GI also recommending EUS in 6 to 8 weeks Tolerating regular diet 11/1   Covid-19 Virus Infection with viral pneumonia Acute Hypoxemic Respiratory Failure-improved Date of onset of symptoms: 10/24 Symptoms present on admission: Cough, fever, congestion Date of covid positive test: 1024 Vaccination status: vaccinated Imaging: CXR -Mildly increased perihilar and bibasilar opacities could represent atypical infection and/or edema.  Oxygen requirements on admission: 3L/NC Current oxygen requirements: room air Medical therapy: remdesivir and steroids Anticipated special isolation end date: 11/5 PO Decadron x 6 more days (End date 11/8/23)   Mildly Elevated ALT In the setting of above Monitored LFT's closely in the setting of Remdesevir infusion Improved and almost resolved 156 on admission->52 11/2 Follow with PCP for repeat in 1-2 weeks   Atrial fibrillation Bradycardia Continue home amiodarone and Eliquis Essential HTN Controlled Continue home meds   Hyponatremia - resolved Na+ 137 (11/2)   Constipation - resolved BM documented on 10/31/23
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Oedematous pancreatitis, Pancreatic atrophy, Pancreatic pseudocyst, Pancreatic steatosis, Pancreatitis acute
Clinical narrative: Patient is a 87 y.o. male patient of DO with history of  afib, arthritis, CA, CKD, CAD, GERD, HTN, HLD, MI   presented to Hospital with abdominal pain, back pain.   Acute pancreatitis Noted on CT scan, but with normal lipase No obvious etiology.  Denies alcohol use. Molnupiravir is not noted to cause pancreatitis. Consult GI. Cautiously hydrate this patient who has concurrent COVID-pneumonia. PPI ordered RUQ ultrasound unremarkable 10/30 MRCP showed atrophic changes of the pancreas with areas of fatty infiltration persistent edematous appearance of the caudal aspect of the pancreatic head and process with a small cyst developing pseudocyst in the region.  Recommend short interval MRI pancreas in 1 to 3 months as outpatient.   GI also recommending EUS in 6 to 8 weeks Tolerating regular diet 11/1   Covid-19 Virus Infection with viral pneumonia Acute Hypoxemic Respiratory Failure-improved Date of onset of symptoms: 10/24 Symptoms present on admission: Cough, fever, congestion Date of covid positive test: 1024 Vaccination status: vaccinated Imaging: CXR -Mildly increased perihilar and bibasilar opacities could represent atypical infection and/or edema.  Oxygen requirements on admission: 3L/NC Current oxygen requirements: room air Medical therapy: remdesivir and steroids Anticipated special isolation end date: 11/5 PO Decadron x 6 more days (End date 11/8/23)   Mildly Elevated ALT In the setting of above Monitored LFT's closely in the setting of Remdesevir infusion Improved and almost resolved 156 on admission->52 11/2 Follow with PCP for repeat in 1-2 weeks   Atrial fibrillation Bradycardia Continue home amiodarone and Eliquis Essential HTN Controlled Continue home meds   Hyponatremia - resolved Na+ 137 (11/2)   Constipation - resolved BM documented on 10/31/23
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia viral, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Ultrasound abdomen normal
Clinical narrative: Patient is a 87 y.o. male patient of DO with history of  afib, arthritis, CA, CKD, CAD, GERD, HTN, HLD, MI   presented to Hospital with abdominal pain, back pain.   Acute pancreatitis Noted on CT scan, but with normal lipase No obvious etiology.  Denies alcohol use. Molnupiravir is not noted to cause pancreatitis. Consult GI. Cautiously hydrate this patient who has concurrent COVID-pneumonia. PPI ordered RUQ ultrasound unremarkable 10/30 MRCP showed atrophic changes of the pancreas with areas of fatty infiltration persistent edematous appearance of the caudal aspect of the pancreatic head and process with a small cyst developing pseudocyst in the region.  Recommend short interval MRI pancreas in 1 to 3 months as outpatient.   GI also recommending EUS in 6 to 8 weeks Tolerating regular diet 11/1   Covid-19 Virus Infection with viral pneumonia Acute Hypoxemic Respiratory Failure-improved Date of onset of symptoms: 10/24 Symptoms present on admission: Cough, fever, congestion Date of covid positive test: 1024 Vaccination status: vaccinated Imaging: CXR -Mildly increased perihilar and bibasilar opacities could represent atypical infection and/or edema.  Oxygen requirements on admission: 3L/NC Current oxygen requirements: room air Medical therapy: remdesivir and steroids Anticipated special isolation end date: 11/5 PO Decadron x 6 more days (End date 11/8/23)   Mildly Elevated ALT In the setting of above Monitored LFT's closely in the setting of Remdesevir infusion Improved and almost resolved 156 on admission->52 11/2 Follow with PCP for repeat in 1-2 weeks   Atrial fibrillation Bradycardia Continue home amiodarone and Eliquis Essential HTN Controlled Continue home meds   Hyponatremia - resolved Na+ 137 (11/2)   Constipation - resolved BM documented on 10/31/23
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Palpitations
Clinical narrative: Heart thumping hard for about 3 minutes.  A few days later my heart was beating really fast for a couple of minutes.
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE GIVEN AFTER VIABILITY DATE.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Renal cancer, Thrombosis
Clinical narrative: Thromboses renal cancer
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE GIVEN AFTER VIABILITY DATE.
Age: 1.5
Sex: F
Vaccine: DTAPIPV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient came in for WCC and Immunizations. Patient was due for Dtap, IPV, and Hep A. MA gave a Kinrix. MA was emailed and coached. Manager and Assistance Manager were both notified. Safety was reported.  Medical director was also notified and parent was notified that incorrect vaccine was given. No issues with the patient since receiving the vaccine.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Headache, Nasal congestion, Nausea, SARS-CoV-2 test, Sinus disorder
Clinical narrative: Nausea, headache, nasal congestion, sinus problem
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE GIVEN AFTER VIABILITY DATE
Age: 18.0
Sex: M
Vaccine: MENB
Symptoms: Injection site pain, Pyrexia, Urticaria, Vomiting
Clinical narrative: Patient reported developing high fever, hives, pain in left arm (site of injection), and vomiting.   Patient took Benadryl and Claritin with some relief, though hives continued to develop in different areas of body.  Patient very itchy and uncomfortable.  Provider prescribed PREDNISONE  4 x 10 mg Tablet 4 tab PO As Directed; for 7 days; 4 tabs PO QD x 3 days, then 2 tabs PO QD x 2 days, then 1 tab PO QD x 2 days administer with food or milk Quantity: 18 Tablet(s), 0 refills which helped.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE GIVEN AFTER VIABILITY DATE
Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Fever (101); chills, body ache lasting 12 hours
Age: 81.0
Sex: F
Vaccine: FLUA4
Symptoms: Arrhythmia, Chest discomfort, Dry mouth, Thirst
Clinical narrative: Arrhythmia, tight chest, dry mouth, increased thirst. At 9 AM  next day- now!- 12-27 I still have arrhthmia, my heart rate is 118. I am on a low salt diet. I'm going to call my doctor  when he opens if I'm still having arrhythmia.
Age: 63.0
Sex: M
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: VACCINE FROZEN INSTEAD OF REFRIGERATED
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Amyotrophic lateral sclerosis, Aphasia, Balance disorder, Death, Dysphagia
Clinical narrative: Loss in balance, loss of talking ability, loss of walking, loss of eating, loss swallowing, loss hand movement, loss total independence of daily activities, became totally dependent of care until she passed. Diagnosed with ALS.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Feeding disorder, Gait inability, Laboratory test, Loss of personal independence in daily activities, Musculoskeletal disorder
Clinical narrative: Loss in balance, loss of talking ability, loss of walking, loss of eating, loss swallowing, loss hand movement, loss total independence of daily activities, became totally dependent of care until she passed. Diagnosed with ALS.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Extra dose of covid vaccine was given. No adverse effects, patient stable.
Age: 16.0
Sex: M
Vaccine: FLUC4
Symptoms: Extra dose administered
Clinical narrative: Resident was given this vaccine per vaccine date provided but went to the health dept and was given the vaccine again on 12/27. Questioning if there are any concerns re this.
Age: 16.0
Sex: M
Vaccine: COVID19, FLUC4
Symptoms: Extra dose administered
Clinical narrative: Administered a 2nd time on 12/27
Age: 60.0
Sex: F
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: Adult patient was administered the pediatric version of Engerix-B. We contacted the manufacturer and they advised 2 options: 1) Patient can be given an additional pediatric dose of Engerix-B if given in the same day to count as 1 dose, 2) Patient can be given 1 adult dose of Engerix-B 2 months after date of incorrect vaccine administration. The patient came back into the clinic on 12-26-23 and was given the 2nd dose of pediatric Engerix-B, no further action necessary.
Age: 57.0
Sex: M
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: VACCINE FROZEN INSTEAD OF REFRIGERATED
Age: 27.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Patient reported she became lightheaded after receiving first vaccine (flu in left arm) around 10:35am . Patient received second vaccine (covid) a few seconds later in right arm around (10:36).  A couple minutes later around 10:38 patient reported to more lightheadedness after standing for a minute then reported feeling nauseous.  After sitting patient vomited around 10:40am clear liquids only.  Patient waited for 30 minutes after receiving both vaccines and reported no further symptoms.  Called patient at 12:40pm and patient reported no further symptoms 2 hours later.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Axillary pain, Inflammation, Neck pain, Pain
Clinical narrative: extreme soreness from elbow up through the shoulder, trap and neck and down around clavicle to under the arm. tingling from thumb up arm to shoulder. Most likely due to inflammation.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity, Paraesthesia
Clinical narrative: extreme soreness from elbow up through the shoulder, trap and neck and down around clavicle to under the arm. tingling from thumb up arm to shoulder. Most likely due to inflammation.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Product storage error
Clinical narrative: VACINE FROZEN INSTEAD OF REFRIGERATED
Age: 0.08
Sex: F
Vaccine: RSV
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
Clinical narrative: Patient administered incorrect RSV shot - Beyfortus ordered, Abrysvo given.
Sex: F
Vaccine: FLU4, HEP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: newborn inadvertently given Fluarix instead of Engerix.  Patient monitored and had no adverse reactions.
Age: 2.0
Sex: M
Vaccine: DTAP, HEPA, HIBV, MMR, PNC20, VARCEL
Symptoms: Extra dose administered
Clinical narrative: Pt had received his 12 month vaccinations of 1/25/2022. Pts name has an apostrophe in it so the immunization record did not pull into the medical record we use. Record was not double checked with the state and pt was given his 12 month vaccinations again on 11/3/2023. No additional treatment needed.
Age: 79.0
Sex: M
Vaccine: FLUA4
Symptoms: Haematoma, Pain
Clinical narrative: A large hematoma in right arm , and pain .
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient given vaccine that was manufactured for 6m - 11yrs.  No symptoms reported.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood creatinine increased, Blood pressure increased, COVID-19, Cerebral infarction
Clinical narrative: Patient Is a 79 y.o. male with PMH of OSA< CVA, GERD, DM#, CAD, CKD, PAF who presented to hospital with acute on chronic AMS, generally thought to be unwell and was found to have COVID with viral sepsis.    Covid 19 viral infection- improved Acute hypoxic respiratory failure- resolved Viral sepsis, POA  Septic on admission, requiring 2L O2  Covid + 10/30/23, (unclear sx onset)  10/30 CXR w/ prominent pulm vasculature and hazy opacities bilat (Edema vs pna)  Remaining infectious w/u negative  Decadron 10/30-11/8, DC with 5 additional days  Will be out of special isolation 11/10 (10/30 day 0, out on day 11)  Has been on room air since 11/1, respiratory symptoms resolved   Acute metabolic encephalopathy - resolving Chronic cognitive impairments Reportedly w/ lethargy/decreased mental status at ECF, only oriented to self. Repetitive answers to questions, non sensicle responses & refusing care at times.  At baseline he is able to hold a conversation per his brother, watches sport games, interactive etc.  Suspect exacerbated by Covid/fever/hypoxia  Recent CVA Sept '23 w/ concerns for underlying dementia  10/30 CTH evolving subacute/chronic R periventricular infarcts (c/w prior) No new focal deficits, hold repeat MRI  Huge improvements from 11/1 to 11/3 Now very near previous baseline  Sitting up, interactive, able to recall events from days prior, conversational OK with DC plan home; spoke w brother and LVM for son  Returning to SNF  Hx of CVA 9/2023 Admitted Sept '23, new subacute R periventricular infacrt, chronic small vessel disease, chronic lacunar infarct  Admit imaging fairly unchanged  Continue ASA/Plavix, Statin and risk factor mgmt  Follow up neurology as OP  Reminded brother of Stroke clinic f/u; info on AVS    CAD  Prior stents, asymptomatic on arrival   Chronically elevated troponin in setting of CKD   EKG no new ischemic changes  Continue medical therapy     Diabetes, type II A1c 6.6% on 9/16/23. Continue basal regimen  SSI added and monitor    CKD III Admit Cr 1.62 ( baseline ~1.8 -2) At baseline during admission    Emphysema NSCLC s/p RUL lobectomy for NSCLC 7/14/23, stage IA2 No active wheezing  outpatient follow up    OSA CPAP ordered    Hypertension, essential BP variable and elevated  Continue home medications and monitor High when his BP meds wear off May need titration of meds as OP   Prostate cancer Urinary retention per note Jan 2023, patient declined surgical option but elected for radiation treatment Continue oxybyutynin
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral small vessel ischaemic disease, Cerebrovascular accident, Chest X-ray abnormal, Cognitive disorder, Computerised tomogram head abnormal
Clinical narrative: Patient Is a 79 y.o. male with PMH of OSA< CVA, GERD, DM#, CAD, CKD, PAF who presented to hospital with acute on chronic AMS, generally thought to be unwell and was found to have COVID with viral sepsis.    Covid 19 viral infection- improved Acute hypoxic respiratory failure- resolved Viral sepsis, POA  Septic on admission, requiring 2L O2  Covid + 10/30/23, (unclear sx onset)  10/30 CXR w/ prominent pulm vasculature and hazy opacities bilat (Edema vs pna)  Remaining infectious w/u negative  Decadron 10/30-11/8, DC with 5 additional days  Will be out of special isolation 11/10 (10/30 day 0, out on day 11)  Has been on room air since 11/1, respiratory symptoms resolved   Acute metabolic encephalopathy - resolving Chronic cognitive impairments Reportedly w/ lethargy/decreased mental status at ECF, only oriented to self. Repetitive answers to questions, non sensicle responses & refusing care at times.  At baseline he is able to hold a conversation per his brother, watches sport games, interactive etc.  Suspect exacerbated by Covid/fever/hypoxia  Recent CVA Sept '23 w/ concerns for underlying dementia  10/30 CTH evolving subacute/chronic R periventricular infarcts (c/w prior) No new focal deficits, hold repeat MRI  Huge improvements from 11/1 to 11/3 Now very near previous baseline  Sitting up, interactive, able to recall events from days prior, conversational OK with DC plan home; spoke w brother and LVM for son  Returning to SNF  Hx of CVA 9/2023 Admitted Sept '23, new subacute R periventricular infacrt, chronic small vessel disease, chronic lacunar infarct  Admit imaging fairly unchanged  Continue ASA/Plavix, Statin and risk factor mgmt  Follow up neurology as OP  Reminded brother of Stroke clinic f/u; info on AVS    CAD  Prior stents, asymptomatic on arrival   Chronically elevated troponin in setting of CKD   EKG no new ischemic changes  Continue medical therapy     Diabetes, type II A1c 6.6% on 9/16/23. Continue basal regimen  SSI added and monitor    CKD III Admit Cr 1.62 ( baseline ~1.8 -2) At baseline during admission    Emphysema NSCLC s/p RUL lobectomy for NSCLC 7/14/23, stage IA2 No active wheezing  outpatient follow up    OSA CPAP ordered    Hypertension, essential BP variable and elevated  Continue home medications and monitor High when his BP meds wear off May need titration of meds as OP   Prostate cancer Urinary retention per note Jan 2023, patient declined surgical option but elected for radiation treatment Continue oxybyutynin
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Disorientation, Electrocardiogram normal, Emphysema, Glycosylated haemoglobin normal
Clinical narrative: Patient Is a 79 y.o. male with PMH of OSA< CVA, GERD, DM#, CAD, CKD, PAF who presented to hospital with acute on chronic AMS, generally thought to be unwell and was found to have COVID with viral sepsis.    Covid 19 viral infection- improved Acute hypoxic respiratory failure- resolved Viral sepsis, POA  Septic on admission, requiring 2L O2  Covid + 10/30/23, (unclear sx onset)  10/30 CXR w/ prominent pulm vasculature and hazy opacities bilat (Edema vs pna)  Remaining infectious w/u negative  Decadron 10/30-11/8, DC with 5 additional days  Will be out of special isolation 11/10 (10/30 day 0, out on day 11)  Has been on room air since 11/1, respiratory symptoms resolved   Acute metabolic encephalopathy - resolving Chronic cognitive impairments Reportedly w/ lethargy/decreased mental status at ECF, only oriented to self. Repetitive answers to questions, non sensicle responses & refusing care at times.  At baseline he is able to hold a conversation per his brother, watches sport games, interactive etc.  Suspect exacerbated by Covid/fever/hypoxia  Recent CVA Sept '23 w/ concerns for underlying dementia  10/30 CTH evolving subacute/chronic R periventricular infarcts (c/w prior) No new focal deficits, hold repeat MRI  Huge improvements from 11/1 to 11/3 Now very near previous baseline  Sitting up, interactive, able to recall events from days prior, conversational OK with DC plan home; spoke w brother and LVM for son  Returning to SNF  Hx of CVA 9/2023 Admitted Sept '23, new subacute R periventricular infacrt, chronic small vessel disease, chronic lacunar infarct  Admit imaging fairly unchanged  Continue ASA/Plavix, Statin and risk factor mgmt  Follow up neurology as OP  Reminded brother of Stroke clinic f/u; info on AVS    CAD  Prior stents, asymptomatic on arrival   Chronically elevated troponin in setting of CKD   EKG no new ischemic changes  Continue medical therapy     Diabetes, type II A1c 6.6% on 9/16/23. Continue basal regimen  SSI added and monitor    CKD III Admit Cr 1.62 ( baseline ~1.8 -2) At baseline during admission    Emphysema NSCLC s/p RUL lobectomy for NSCLC 7/14/23, stage IA2 No active wheezing  outpatient follow up    OSA CPAP ordered    Hypertension, essential BP variable and elevated  Continue home medications and monitor High when his BP meds wear off May need titration of meds as OP   Prostate cancer Urinary retention per note Jan 2023, patient declined surgical option but elected for radiation treatment Continue oxybyutynin
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoxia, Imaging procedure abnormal, Laboratory test normal, Lacunar infarction, Lethargy
Clinical narrative: Patient Is a 79 y.o. male with PMH of OSA< CVA, GERD, DM#, CAD, CKD, PAF who presented to hospital with acute on chronic AMS, generally thought to be unwell and was found to have COVID with viral sepsis.    Covid 19 viral infection- improved Acute hypoxic respiratory failure- resolved Viral sepsis, POA  Septic on admission, requiring 2L O2  Covid + 10/30/23, (unclear sx onset)  10/30 CXR w/ prominent pulm vasculature and hazy opacities bilat (Edema vs pna)  Remaining infectious w/u negative  Decadron 10/30-11/8, DC with 5 additional days  Will be out of special isolation 11/10 (10/30 day 0, out on day 11)  Has been on room air since 11/1, respiratory symptoms resolved   Acute metabolic encephalopathy - resolving Chronic cognitive impairments Reportedly w/ lethargy/decreased mental status at ECF, only oriented to self. Repetitive answers to questions, non sensicle responses & refusing care at times.  At baseline he is able to hold a conversation per his brother, watches sport games, interactive etc.  Suspect exacerbated by Covid/fever/hypoxia  Recent CVA Sept '23 w/ concerns for underlying dementia  10/30 CTH evolving subacute/chronic R periventricular infarcts (c/w prior) No new focal deficits, hold repeat MRI  Huge improvements from 11/1 to 11/3 Now very near previous baseline  Sitting up, interactive, able to recall events from days prior, conversational OK with DC plan home; spoke w brother and LVM for son  Returning to SNF  Hx of CVA 9/2023 Admitted Sept '23, new subacute R periventricular infacrt, chronic small vessel disease, chronic lacunar infarct  Admit imaging fairly unchanged  Continue ASA/Plavix, Statin and risk factor mgmt  Follow up neurology as OP  Reminded brother of Stroke clinic f/u; info on AVS    CAD  Prior stents, asymptomatic on arrival   Chronically elevated troponin in setting of CKD   EKG no new ischemic changes  Continue medical therapy     Diabetes, type II A1c 6.6% on 9/16/23. Continue basal regimen  SSI added and monitor    CKD III Admit Cr 1.62 ( baseline ~1.8 -2) At baseline during admission    Emphysema NSCLC s/p RUL lobectomy for NSCLC 7/14/23, stage IA2 No active wheezing  outpatient follow up    OSA CPAP ordered    Hypertension, essential BP variable and elevated  Continue home medications and monitor High when his BP meds wear off May need titration of meds as OP   Prostate cancer Urinary retention per note Jan 2023, patient declined surgical option but elected for radiation treatment Continue oxybyutynin
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Lung lobectomy, Lung opacity, Magnetic resonance imaging head abnormal, Malaise, Mental status changes
Clinical narrative: Patient Is a 79 y.o. male with PMH of OSA< CVA, GERD, DM#, CAD, CKD, PAF who presented to hospital with acute on chronic AMS, generally thought to be unwell and was found to have COVID with viral sepsis.    Covid 19 viral infection- improved Acute hypoxic respiratory failure- resolved Viral sepsis, POA  Septic on admission, requiring 2L O2  Covid + 10/30/23, (unclear sx onset)  10/30 CXR w/ prominent pulm vasculature and hazy opacities bilat (Edema vs pna)  Remaining infectious w/u negative  Decadron 10/30-11/8, DC with 5 additional days  Will be out of special isolation 11/10 (10/30 day 0, out on day 11)  Has been on room air since 11/1, respiratory symptoms resolved   Acute metabolic encephalopathy - resolving Chronic cognitive impairments Reportedly w/ lethargy/decreased mental status at ECF, only oriented to self. Repetitive answers to questions, non sensicle responses & refusing care at times.  At baseline he is able to hold a conversation per his brother, watches sport games, interactive etc.  Suspect exacerbated by Covid/fever/hypoxia  Recent CVA Sept '23 w/ concerns for underlying dementia  10/30 CTH evolving subacute/chronic R periventricular infarcts (c/w prior) No new focal deficits, hold repeat MRI  Huge improvements from 11/1 to 11/3 Now very near previous baseline  Sitting up, interactive, able to recall events from days prior, conversational OK with DC plan home; spoke w brother and LVM for son  Returning to SNF  Hx of CVA 9/2023 Admitted Sept '23, new subacute R periventricular infacrt, chronic small vessel disease, chronic lacunar infarct  Admit imaging fairly unchanged  Continue ASA/Plavix, Statin and risk factor mgmt  Follow up neurology as OP  Reminded brother of Stroke clinic f/u; info on AVS    CAD  Prior stents, asymptomatic on arrival   Chronically elevated troponin in setting of CKD   EKG no new ischemic changes  Continue medical therapy     Diabetes, type II A1c 6.6% on 9/16/23. Continue basal regimen  SSI added and monitor    CKD III Admit Cr 1.62 ( baseline ~1.8 -2) At baseline during admission    Emphysema NSCLC s/p RUL lobectomy for NSCLC 7/14/23, stage IA2 No active wheezing  outpatient follow up    OSA CPAP ordered    Hypertension, essential BP variable and elevated  Continue home medications and monitor High when his BP meds wear off May need titration of meds as OP   Prostate cancer Urinary retention per note Jan 2023, patient declined surgical option but elected for radiation treatment Continue oxybyutynin
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic encephalopathy, Non-small cell lung cancer stage I, Obstructive sleep apnoea syndrome, Pneumonia, Prostate cancer
Clinical narrative: Patient Is a 79 y.o. male with PMH of OSA< CVA, GERD, DM#, CAD, CKD, PAF who presented to hospital with acute on chronic AMS, generally thought to be unwell and was found to have COVID with viral sepsis.    Covid 19 viral infection- improved Acute hypoxic respiratory failure- resolved Viral sepsis, POA  Septic on admission, requiring 2L O2  Covid + 10/30/23, (unclear sx onset)  10/30 CXR w/ prominent pulm vasculature and hazy opacities bilat (Edema vs pna)  Remaining infectious w/u negative  Decadron 10/30-11/8, DC with 5 additional days  Will be out of special isolation 11/10 (10/30 day 0, out on day 11)  Has been on room air since 11/1, respiratory symptoms resolved   Acute metabolic encephalopathy - resolving Chronic cognitive impairments Reportedly w/ lethargy/decreased mental status at ECF, only oriented to self. Repetitive answers to questions, non sensicle responses & refusing care at times.  At baseline he is able to hold a conversation per his brother, watches sport games, interactive etc.  Suspect exacerbated by Covid/fever/hypoxia  Recent CVA Sept '23 w/ concerns for underlying dementia  10/30 CTH evolving subacute/chronic R periventricular infarcts (c/w prior) No new focal deficits, hold repeat MRI  Huge improvements from 11/1 to 11/3 Now very near previous baseline  Sitting up, interactive, able to recall events from days prior, conversational OK with DC plan home; spoke w brother and LVM for son  Returning to SNF  Hx of CVA 9/2023 Admitted Sept '23, new subacute R periventricular infacrt, chronic small vessel disease, chronic lacunar infarct  Admit imaging fairly unchanged  Continue ASA/Plavix, Statin and risk factor mgmt  Follow up neurology as OP  Reminded brother of Stroke clinic f/u; info on AVS    CAD  Prior stents, asymptomatic on arrival   Chronically elevated troponin in setting of CKD   EKG no new ischemic changes  Continue medical therapy     Diabetes, type II A1c 6.6% on 9/16/23. Continue basal regimen  SSI added and monitor    CKD III Admit Cr 1.62 ( baseline ~1.8 -2) At baseline during admission    Emphysema NSCLC s/p RUL lobectomy for NSCLC 7/14/23, stage IA2 No active wheezing  outpatient follow up    OSA CPAP ordered    Hypertension, essential BP variable and elevated  Continue home medications and monitor High when his BP meds wear off May need titration of meds as OP   Prostate cancer Urinary retention per note Jan 2023, patient declined surgical option but elected for radiation treatment Continue oxybyutynin
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary oedema, Pulmonary vascular disorder, Pyrexia, Radiotherapy, Repetitive speech
Clinical narrative: Patient Is a 79 y.o. male with PMH of OSA< CVA, GERD, DM#, CAD, CKD, PAF who presented to hospital with acute on chronic AMS, generally thought to be unwell and was found to have COVID with viral sepsis.    Covid 19 viral infection- improved Acute hypoxic respiratory failure- resolved Viral sepsis, POA  Septic on admission, requiring 2L O2  Covid + 10/30/23, (unclear sx onset)  10/30 CXR w/ prominent pulm vasculature and hazy opacities bilat (Edema vs pna)  Remaining infectious w/u negative  Decadron 10/30-11/8, DC with 5 additional days  Will be out of special isolation 11/10 (10/30 day 0, out on day 11)  Has been on room air since 11/1, respiratory symptoms resolved   Acute metabolic encephalopathy - resolving Chronic cognitive impairments Reportedly w/ lethargy/decreased mental status at ECF, only oriented to self. Repetitive answers to questions, non sensicle responses & refusing care at times.  At baseline he is able to hold a conversation per his brother, watches sport games, interactive etc.  Suspect exacerbated by Covid/fever/hypoxia  Recent CVA Sept '23 w/ concerns for underlying dementia  10/30 CTH evolving subacute/chronic R periventricular infarcts (c/w prior) No new focal deficits, hold repeat MRI  Huge improvements from 11/1 to 11/3 Now very near previous baseline  Sitting up, interactive, able to recall events from days prior, conversational OK with DC plan home; spoke w brother and LVM for son  Returning to SNF  Hx of CVA 9/2023 Admitted Sept '23, new subacute R periventricular infacrt, chronic small vessel disease, chronic lacunar infarct  Admit imaging fairly unchanged  Continue ASA/Plavix, Statin and risk factor mgmt  Follow up neurology as OP  Reminded brother of Stroke clinic f/u; info on AVS    CAD  Prior stents, asymptomatic on arrival   Chronically elevated troponin in setting of CKD   EKG no new ischemic changes  Continue medical therapy     Diabetes, type II A1c 6.6% on 9/16/23. Continue basal regimen  SSI added and monitor    CKD III Admit Cr 1.62 ( baseline ~1.8 -2) At baseline during admission    Emphysema NSCLC s/p RUL lobectomy for NSCLC 7/14/23, stage IA2 No active wheezing  outpatient follow up    OSA CPAP ordered    Hypertension, essential BP variable and elevated  Continue home medications and monitor High when his BP meds wear off May need titration of meds as OP   Prostate cancer Urinary retention per note Jan 2023, patient declined surgical option but elected for radiation treatment Continue oxybyutynin